Physician

Llewelyn Anthony Williams, M.D.

According to 2025 Medicare claims, Llewelyn Williams, M.D. (NPI: 1316922750) practices anesthesiology in the Las Cruces, NM market, with the plurality of this provider's patient population coming from Dona Ana, NM. This provider's primary affiliated billing organization is AGAPE PAIN MANAGEMENT AND ANESTHESIA, LLC (NPI: 1891076519; TIN: 452595926) and primary practice location at 88001-8411.

Williams' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 250 traditional Medicare patients, billed 5,985 HCPCS/CPT codes, and received $276,419 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 6,246 prescription claims across 653 beneficiaries totaling $145,282 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). DME data shows 60 claims. Open Payments data shows 27 records totaling $1,880. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $149,868 to $276,419. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $169,712 to $145,282. For DME billing, this smaller-volume category moved sharply higher in recent years, from $2,004 to $3,975.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	452	1,904	$149,868
2016	455	2,891	$157,309
2017	480	3,268	$194,363
2018	430	3,986	$200,402
2019	397	5,433	$210,112
2020	290	4,049	$211,081
2021	225	4,011	$213,191
2022	279	4,059	$258,777
2023	276	6,571	$294,657
2024	250	5,985	$276,419

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	578	3,604	$169,712
2016	700	7,566	$325,094
2017	722	7,902	$334,835
2018	693	6,109	$317,698
2019	662	6,586	$267,694
2020	541	4,845	$149,437
2021	425	3,882	$122,024
2022	574	4,920	$134,617
2023	681	6,135	$182,865
2024	653	6,246	$145,282

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	31	$1,183
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$580
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	71	$5,170
2024	N/R	60	$3,975

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	88	132	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	188	645	$82
80307	Testing for presence of drug, by chemistry analyzers	137	241	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	163	420	$54
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	82	310	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	90	2,554	$14,540
Buprenorphine	Buprenorphine	48	1,348	$12,026
Gabapentin	Gabapentin	729	24,529	$8,265
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	636	16,274	$8,190
Belbuca	Buprenorphine Hcl	11	277	$8,118

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	60	$3,975

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$1,880	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Llewelyn Anthony Williams, M.D.?

Tedicare shows public-source Medicare data for Llewelyn Anthony Williams, M.D. (NPI 1316922750), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Llewelyn Anthony Williams, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Llewelyn Anthony Williams, M.D.?

Llewelyn Anthony Williams, M.D. is linked to AGAPE PAIN MANAGEMENT AND ANESTHESIA, LLC (billing NPI 1891076519) in the available physician profile data.

Does Llewelyn Anthony Williams, M.D. have Open Payments data?

Llewelyn Anthony Williams, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.